Attitudes Toward COVID‐19 Vaccination Among Pediatric Acute Lymphoblastic Leukemia Patients and Their Caregivers Attitudes Toward COVID‐19 Vaccination Among Pediatric Acute Lymphoblastic Leukemia Patients and Their Caregivers
The COVID-19 vaccine is indicated for children with acute lymphoblastic leukemia (ALL), yet patients and caregivers may have unique questions and concerns about vaccination. We surveyed children with ALL or their caregivers (N = 44) to understand factors contributing to the decision to vaccinate and identify cues to vaccination tailored to this population. For caregivers of unvaccinated ALL patients, lack of knowledge about the COVID-19 vaccine and concerns about vaccine safety and efficacy were the most reported barriers to vaccination. A recommendation from a hematologist/oncologist and vaccine safety and efficacy data in children with ALL were the most cited cues to vaccination.
The COVID-19 vaccine is indicated for children with acute lymphoblastic leukemia (ALL), yet patients and caregivers may have unique questions and concerns about vaccination. We surveyed children with ALL or their caregivers (N = 44) to understand factors contributing to the decision to vaccinate and identify cues to vaccination tailored to this population. For caregivers of unvaccinated ALL patients, lack of knowledge about the COVID-19 vaccine and concerns about vaccine safety and efficacy were the most reported barriers to vaccination. A recommendation from a hematologist/oncologist and vaccine safety and efficacy data in children with ALL were the most cited cues to vaccination.